Lv3
240 积分 2022-12-05 加入
我国小核酸药物研发与注册的相关问题研究
4天前
已完结
Current Advances in the Treatment of BRAF-Mutant Melanoma
4个月前
已完结
Dabrafenib plus trametinib in patients with previously untreated BRAFV600E-mutant metastatic non-small-cell lung cancer: an open-label, phase 2 trial. Lancet Oncol. 2017;18(10):1307-1316
4个月前
已完结
An open-label phase 2 trial of dabrafenib plus trametinib in patients with p
4个月前
已完结
Advances in anti-BRAF therapies for lung cancer
4个月前
已关闭
Tabernero J, Grothey A, Van Cutsem E, colorectal cancer: Updated survival results and subgroup analyses from the BEACON study. J Clin Oncol 39:273-284, 2021
4个月前
已关闭
Clinical development of BRAF plus MEK inhibitor combinations
4个月前
已完结
J Natl Cancer Cent. 2024;4(1):page
4个月前
已完结
银屑病共病的研究进展
1年前
已完结
Radiological protection in biomedical research
2年前
已完结
皖公网安备34019202002308
